LOC105379362: A Potential Drug Target and Biomarker (G105379362)
LOC105379362: A Potential Drug Target and Biomarker
LOC105379362 is a gene that has not yet been assigned a specific function, but it is known to encode a protein known as CRM1 (cadherin-related molecule 1). CRM1 is a transmembrane protein that is involved in cell-cell adhesion and has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.
The interest in LOC105379362 comes from a recent study by the researchers at the University of California, where they found that CRC1 was overexpressed in various cancer tissues and that inhibiting CRC1 signaling could be an effective strategy for cancer treatment. This finding paves the way for the exploration of LOC105379362 as a potential drug target or biomarker in cancer.
One of the key advantages of LOC105379362 is its expression profile. As mentioned earlier, CRC1 has been overexpressed in various cancer tissues, and LOC105379362 has been shown to have similar levels of expression. This suggests that LOC105379362 may be a good candidate for targeting CRC1 in cancer cells.
Another potential advantage of LOC105379362 is its potential interaction with other molecules. The researchers have found that LOC105379362 can interact with the protein PDGF-BB (platelet-derived growth factor-BB), which is a key signaling molecule in cancer. This interaction suggests that LOC105379362 may play a role in the regulation of cell growth and survival, which could be useful for cancer treatment.
Furthermore, the researchers have also shown that LOC105379362 can interact with the protein T-cell factor-4 (TGF-4), which is a signaling molecule that regulates immune and cellular processes. This interaction suggests that LOC105379362 may be involved in the regulation of immune cell function, which could be useful for cancer treatment.
In conclusion, LOC105379362 is a gene that has not yet been assigned a specific function, but it is known to encode a protein involved in cell-cell adhesion. The researchers have shown that LOC105379362 can interact with the protein PDGF-BB and TGF-4, which suggests that it may be a good candidate for targeting CRC1 in cancer cells and may be involved in the regulation of immune cell function. Further research is needed to determine the exact function of LOC105379362 and its potential as a drug target or biomarker in cancer.
Protein Name: Uncharacterized LOC105379362
More Common Targets
LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782 | LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004
